IP Library › Assignment 071083/0330
Patent Assignment
Reel/Frame 071083/0330

Release of Security Interest

Recorded: 2025-04-27 Pages: 24
Assignor
Assignees
BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
C/O BIOHAVEN PHARMACEUTICALS, INC., 215 CHURCH STREET, NEW HAVEN, CONNECTICUT, 06510
BIOHAVEN THERAPEUTICS LTD.
C/O BIOHAVEN PHARMACEUTICALS, INC., 215 CHURCH STREET, NEW HAVEN, CONNECTICUT, 06510
BIOHAVEN PHARMACEUTICAL IRELAND DESIGNATED ACTIVITY COMPANY
C/O BIOHAVEN PHARMACEUTICALS, INC., 215 CHURCH STREET, NEW HAVEN, CONNECTICUT, 06510
Covered Properties (41)
Universal Abt Compounds and Uses Thereof
CD16A Binding Agents and Uses Thereof
Combination Therapy of Arms and Natural Killer Cells
Formulation for Oral Delivery of Proteins, Peptides and Small Molecules with Poor Permeability
CD38-Binding Agents and Uses Thereof
Molecules That Bind to Tdp-43 for the Treatment of Amyotrophic Lateral Sclerosis and Related Disorders
Prodrugs of Myeloperoxidase Inhibitors
Directed Conjugation Technologies
Method of Treating Amyotrophic Lateral Sclerosis with Myeloperoxidase Inhibitor
Technologies for Preventing or Treating Infections
Process for the Preparation of Verdiperstat
Topical Formulations of (1S)-1-Phenyl-2-Pyridin-2-Ylethanamine
Compositions and Methods for Treating Obsessive-Compulsive Disorder
Riluzole Prodrugs and Their Use
Application: 15/549,154 →
Publication: US 2018/0036290
Use of Riluzole Oral Disintegrating Tablets for Treating Diseases
Application: 17/056,559 →
Publication: US 2022/0218673
Sublingual Formulation of Riluzole
Application: 17/079,498 →
Publication: US 2021/0038499
Prodrugs of Riluzole and Their Method of Use
Application: 17/101,239 →
Publication: US 2021/0078962
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Application: 17/151,577 →
Publication: US 2021/0212999
Prodrugs of Riluzole and Their Method of Use
Application: 17/151,582 →
Publication: US 2021/0236470
Riluzole Prodrugs and Their Use
Application: 17/151,585 →
Publication: US 2021/0228549
Riluzole Prodrugs and Their Use
Application: 17/164,654 →
Publication: US 2021/0236471
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Application: 17/261,057 →
Publication: US 2021/0290599
Use of Riluzole Oral Disintigrating Tablets for Treating Diseases
Application: 17/268,072 →
Publication: US 2021/0315865
Combination Therapy of Arms and Natural Killer Cells
Application: 17/312,419 →
Publication: US 2022/0040231
Riluzole Prodrugs and Their Use
Application: 17/367,484 →
Publication: US 2023/0017637
Use of riluzole oral disintigrating tablets fo treating diseases
Application: 62/764,864 →
Technologies for Treating Sars-Cov-2 Infection
Application: 62/994,779 →
Technologies for Preventing or Treating Infections
Application: 63/001,455 →
Process for the Preparation of Verdiperstat
Application: 63/021,041 →
Topical Formulations of (1S)-1-Phenyl-2-Pyridin-2-Ylethanamine
Application: 63/043,075 →
Compositions and Methods for Treating Obsessive-Compulsive Disorder
Application: 63/043,681 →
Technologies for Preventing or Treating Infections
Application: 63/055,860 →
Use of Riluzole Prodrugs to Treat Alzheimer's Disease
Application: 63/138,669 →
Technologies for Preventing or Treating Infections
Application: 63/146,584 →
Small Molecules That Bind to Tdp-43 for the Treatment of Als and Related Disorders
Application: 63/151,651 →
Technologies for Preventing or Treating Infections
Application: 63/151,785 →
Bifunctional Degraders of Galactose-Deficient Immunoglobulins
Application: 63/159,383 →
Compositions Including Conjugated Therapy Enhancers
Application: 63/189,503 →
Agents for Directed Conjugation Techniques and Conjugated Products
Application: 63/189,522 →
Antibody Drug Conjugates Using Mates Technology for Delivering Cytotoxic Agents
Application: 63/190,703 →
Conjugated Antibodies for Treating Diseases
Application: 63/245,180 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Oct 24, 2017
From: WROBEL, JAY EDWARD; REITZ, ALLEN B.; PELLETIER, JEFFERY CLAUDE; SMITH, GARRY ROBERT
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY, LTD.
Reel/Frame 043928/0565 →
Assignment of Assignor's Interest Aug 27, 2018
From: SPIEGEL, DAVID ADAM; WELSCH, MATTHEW ERNEST
To: KLEO PHARMACEUTICALS, INC.
Reel/Frame 046712/0367 →
Assignment of Assignor's Interest Dec 16, 2018
From: CORIC, VLADIMIR
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 047789/0261 →
Security Interest May 10, 2019
From: KLEO PHARMACEUTICALS, INC.
To: CONNECTICUT INNOVATIONS, INCORPORATED
Reel/Frame 049139/0630 →
Assignment of Assignor's Interest Jun 3, 2019
From: BUNIN, ANNA; IBEN, LAWRENCE G.; MANION, DOUGLAS; SPIEGEL, DAVID ADAM
To: KLEO PHARMACEUTICALS, INC.
Reel/Frame 049349/0100 →
Assignment of Assignor's Interest Aug 15, 2019
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 050067/0386 →
Assignment of Assignor's Interest Oct 16, 2019
From: BIAN, HAIYAN
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 050724/0114 →
Assignment of Assignor's Interest Oct 19, 2019
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 050768/0383 →
Patent Security Agreement Aug 7, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.; BIOHAVEN THERAPEUTICS LTD; BIOHAVEN PHARMACEUTICAL IRELAND DESIGNATED ACTIVITY COMPANY
To: SIXTH STREET SPECIALTY LENDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 053428/0001 →
Assignment of Assignor's Interest Aug 7, 2020
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 053429/0159 →
Assignment of Assignor's Interest Jan 6, 2021
From: SPIEGEL, DAVID ADAM
To: YALE UNIVERSITY
Reel/Frame 054832/0035 →
Assignment of Assignor's Interest Jan 6, 2021
From: SPIEGEL, DAVID ADAM
To: YALE UNIVERSITY
Reel/Frame 054832/0016 →
Assignment of Assignor's Interest Jan 6, 2021
From: SPIEGEL, DAVID ADAM
To: YALE UNIVERSITY
Reel/Frame 054829/0969 →
Release of Security Interest Mar 31, 2021
From: CONNECTICUT INNOVATIONS, INCORPORATED
To: KLEO PHARMACEUTICALS, INC.
Reel/Frame 055789/0558 →
Assignment of Assignor's Interest Jun 3, 2021
From: WELSCH, MATTHEW ERNEST
To: KLEO PHARMACEUTICALS, INC.
Reel/Frame 056424/0875 →
Assignment of Assignor's Interest Jun 4, 2021
From: BUNIN, ANNA
To: KLEO PHARMACEUTICALS, INC.
Reel/Frame 056439/0152 →
Assignment of Assignor's Interest Oct 5, 2021
From: DUBOWCHIK, GENE M.; CONWAY, CHARLES M.
To: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
Reel/Frame 057707/0089 →
Assignment of Assignor's Interest Oct 5, 2021
From: PLASSAT, VINCENT; HILBOLD, BENOIT; GALUS, AURÉLIA; POINTEAUX, THOMAS
To: R.P. SCHERER TECHNOLOGIES, LLC
Reel/Frame 057707/0078 →
Patent Security Agreement Dec 2, 2021
From: BIOHAVEN THERAPEUTICS LTD.
To: SIXTH STREET SPECIALTY LENDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 058299/0273 →
Patent Security Agreement Dec 2, 2021
From: BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD.
To: SIXTH STREET SPECIALTY LENDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 058299/0297 →
Patent Security Agreement Dec 2, 2021
From: KLEO PHARMACEUTICALS INC.
To: SIXTH STREET SPECIALTY LENDING, INC., AS ADMINISTRATIVE AGENT
Reel/Frame 058299/0321 →
Assignment of Assignor's Interest Jun 13, 2022
From: KLEO PHARMACEUTICALS, INC.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 060177/0428 →
Assignment of Assignor's Interest Oct 25, 2022
From: ROSSI, ANN MARIE K.; BUNIN, ANNA; RASTELLI, LUCA; WELSCH, MATTHEW ERNEST
To: KLEO PHARMACEUTICALS, INC.
Reel/Frame 061522/0852 →
Assignment of Assignor's Interest Oct 25, 2022
From: JIN, XIAO
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 061527/0324 →
Assignment of Assignor's Interest Oct 31, 2022
From: BERMAN, ROBERT; KUMAR, RAJESH; CONWAY, CHARLES M.; DONOHUE, MARY K.
To: BIOHAVEN THERAPEUTICS LTD.
Reel/Frame 061589/0246 →